Mrv2304 05312316092D 20 18 0 0 1 0 999 V2000 -1.5004 1.1963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7859 0.7837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0714 1.1963 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.7859 -0.0413 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.0714 -0.4538 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.0714 -1.2788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6430 -1.6913 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 0.6430 -0.0412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6430 0.7838 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.3575 -0.4538 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.7146 -0.2062 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 4.4291 0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.1436 -0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.8581 0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.5725 -0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.2870 0.2062 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 7.2870 1.0312 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 8.0015 -0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.7159 0.2062 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 8.0015 -1.0313 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 2 0 0 0 0 2 4 1 0 0 0 0 5 4 1 6 0 0 0 5 6 1 0 0 0 0 6 7 1 0 0 0 0 5 8 1 0 0 0 0 8 9 1 0 0 0 0 8 10 2 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 13 14 1 0 0 0 0 14 15 1 0 0 0 0 16 15 1 0 0 0 0 16 17 1 6 0 0 0 16 18 1 0 0 0 0 18 19 1 0 0 0 0 18 20 2 0 0 0 0 M END > DB17839 > drugbank > CC(=O)N[C@@H](CS)C(O)=O.NCCCC[C@H](N)C(O)=O > InChI=1S/C6H14N2O2.C5H9NO3S/c7-4-2-1-3-5(8)6(9)10;1-3(7)6-4(2-10)5(8)9/h5H,1-4,7-8H2,(H,9,10);4,10H,2H2,1H3,(H,6,7)(H,8,9)/t5-;4-/m00/s1 > YLCSLYZPLGQZJS-VDQHJUMDSA-N > C11H23N3O5S > 309.38 > 309.135842027 > 3 > 43 > 0.8328676994298995 > 15.464901143716071 > 1 > 3 > 0 > 0 > (2R)-2-acetamido-3-sulfanylpropanoic acid; (2S)-2,6-diaminohexanoic acid > -0.7113127423333335 > 0 > -2 > 0 > -2 > 66.4 > 37.66740000000001 > 8 > 1 > nacystelyn > 0 > DB17839 > investigational > Nacystelyn > Acetylcysteine lysine; L-lysine, compd. with n-acetyl-l-cysteine; Lysine acetylcysteinate; Lysine acetylcysteinate salt; N-acetylcysteinate lysine $$$$